# CD4 CAR+ ZFN-modified T Cells in HIV Therapy

> **NCT03617198** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 12 (actual)

## Conditions studied

- Hiv

## Interventions

- **BIOLOGICAL:** CD4 CAR+CCR5 ZFN T-cells

## Key facts

- **NCT ID:** NCT03617198
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-31
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03617198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03617198, "CD4 CAR+ ZFN-modified T Cells in HIV Therapy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03617198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*